@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix go: . @prefix species: . @prefix occursIn: . @prefix obo: . @prefix do: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: do:1936, obo:CL_0000235, obo:UBERON_0001969, species:9606; rdf:object go:0006979; rdf:predicate belv:increases; rdf:subject chebi:26523; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:\"reactive oxygen species\") -> bp(GOBP:\"response to oxidative stress\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "20131211" . sub:_2 prov:value "Newly synthesized heme can be incorporated into heme proteins or, alternatively, can be degraded. Accumulation of intracellular or exogenous (e.g., in blood clot) heme can be detrimental to cells, since heme catalyzes the formation of ROS, resulting in oxidative stress."; prov:wasQuotedFrom pubmed:12869663 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12869663; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:04.840+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }